SingHealth Duke-NUS Academic Medical Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

CIVA and CTDA Awardees Overview

Synonym(s):

 

​A prestigious award that provides protected time of 0.2 FTE for 2 years for experienced CIVs to further develop their research focus. The CIV Advancement Award supports awardees in their journey to become recognised as independent established clinician researchers of international standing, supported by various grants, leading / co-leading research platforms, and contributing as active collaborators and academic clinician leaders in the AMC, ultimately translating research findings.

  1. An established CIV is envisioned to:
    i) Lead a focused research programme / platform
    ii) Have funding to support the research programme / platform
    iii) Have a range of collaborators
    iv) Have a team of support staff, such as Clinical Research Coordinators (CRCs) etc.
    v) Produce good research output in terms of publications, trial participation, innovation and driving clinical services from their research findings
    vi) Be a mentor and nurture emerging researchers

  2. The CIVA is a prestigious award to give recognition and support to CIVs who have plans to further develop and grow their research platform / team / focus. This initiative aims to:
    i) Optimise the research output of productive CIVs
    ii) Grow the research programme / platform of CIVs
    iii) Build the support team of CIVs
    iv) Establish the reputation and profile of CIVs

Each submission must be made using the prescribed forms:

  1. CIV Advancement Award Application Form (to be completed by applicant)
  2. Applicant CV & Career Development Plan (to be completed by applicant)
  3. Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable)).

Applications that fail to comply with requirements in any of the templates and/or incomplete applications will be disqualified and will not be reviewed.



For applicants who are planning to apply for national level funding, are already holding national grants, or are supported by clinical trials with FTE allocation, please state the justification for the need of protected time in your application for the CIV Advancement Award.


For shortlisted applicants, a short interview with the review panel may be required. Details concerning the interview will be disseminated once it is finalised.  For successful applicants, the outcomes of the research programme / platform will be monitored during and after the award tenure. Applicants are expected to submit a Mid-term Progress Report and a Final Report with these outcomes periodically during and after the tenure of the award.